Pharma Journalist 8947 posts 0 comments

As the Program Director of the Microbiome Movement, I would like to formally invite you to join us an esteemed member of the delegation for the inaugural Microbiome Movement – Drug…
Read More...

As scientific researchers continue to investigate the complexities of the skin microbiome, our mission for the 2nd Microbiome Movement – Skin Health & Dermatology Summit is simple:…
Read More...

SMi Reports: Registration is now open for the Inaugural Respiratory Drug Delivery conference taking place in London on 13th-14th November 2019. SMi are pleased to announce that…
Read More...

AstraZeneca has presented three-year overall survival (OS) results from the Phase III PACIFIC trial of Imfinzi (durvalumab) in unresectable, Stage III non-small cell lung cancer (NSCLC)…
Read More...

Biocartis Group NV, an innovative molecular diagnostics company (Euronext Brussels: BCART), announced that it has entered into a Master Development and Commercialization Agreement with…
Read More...

SMi Reports: SMi Group are delighted to announce that registration is open for the 5th Annual Lyophilization USA conference, taking place October 23rd-24th in Boston. Despite being a…
Read More...

SMi Reports: Novartis, SKAN and Taro Pharmaceuticals to speak on containment and banding strategies at the inaugural HPAPI USA conference, taking place on October 21st-22nd in Boston…
Read More...

Boehringer Ingelheim and Gubra announce a second collaboration and license agreement for the development of novel poly-agonist peptides to treat obesity. It will bring together Gubra’s…
Read More...

Particle Sciences, a Lubrizol LifeSciences company and pharmaceutical contract development and manufacturing organization (CDMO), has broadened its Drug Enforcement Administration (DEA)…
Read More...

Merz, a global leader in neurotoxin therapy, announced the European approval of Xeomin (incobotulinumtoxinA) for the symptomatic treatment of chronic sialorrhea (drooling) due to…
Read More...